You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
*ST大藥(603963.SH):擬變更募集資金投資項目
格隆匯 06-26 19:05

格隆匯6月26日丨*ST大藥(603963.SH)公佈,公司擬將原投向由本公司實施的“中藥注射劑二次開發研究項目”、“藥品研發技術中心建設項目”子項目“研發中心建設項目”、“營銷網絡建設項目”(合稱“原項目”)的募集資金,變更為投向由本公司全資子公司銷售公司實施的“大理藥業醫藥配送項目”。本次涉及變更投向的募集資金金額為12,888.04萬元,佔公司實際募集資金總額的49.10%。

同時,為了提高資金使用效率,降低公司財務成本,公司擬將閒置募集資金購買理財產品的實際收益1,138.36萬元(未包含未到期理財產品收益,具體金額以到期贖回該筆理財取得的收益為準),募集資金專户產生的利息12.07萬元(已扣減手續費,具體金額以實際結轉時專户產生的利息為準),合計1,150.43萬元(具體金額以實際結轉時項目專户資金餘額為準)用於永久補充流動資金,計劃用於償還公司到期有息負債及儲備必要的流動資金防範流動性風險。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account